Which therapy eases back pain disability best? a Head-to-Head trial

NCT ID NCT05294081

Completed Disease control Sponsor: University of Kaiserslautern-Landau Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial compares two psychological approaches for chronic low back pain: exposure therapy and cognitive behavioral therapy (CBT). The goal is to see which method better reduces pain-related disability and to identify which patients benefit most from each. Adults with chronic back pain and significant disability will receive 10 sessions of one therapy and be followed for up to two years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Exposure therapy and cognitive behavioral therapy
What this could lead to: If successful, this could help tailor psychological treatments for chronic back pain, improving disability outcomes for specific patient groups.
What could go wrong: The trial is early and results may not apply to all patients. Psychological therapies require active participation and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LOW-BACK PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC LOW-BACK PAIN

Contacts and locations

Locations

Essener Rückenschmerzzentrum, Universitätsklinikum Essen

Essen, 45147, Germany
Phillips-Universität Marburg

Marburg, 35037, Germany
Poliklinische Institutsambulanz für Psychotherapie

Mainz, 55122, Germany
RPTU Kaiserslautern- Landau

Landau, RLP, 76829, Germany
Schmerzzentrum, Ruprechts - Karls Universität Heidelberg

Heidelberg, 69120, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.